Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Coiffier

Showing results (211-220 of 289) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
Leukemia|October 8, 2004
FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)S Camilleri-Broët, N Mounier, A Delmer, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphomaN Ketterer, G Salles, D Espinouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'AdulteA Guerci, P Lederlin, F Reyes, et al.
The American Journal of Medicine|May 7, 1999
Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factorsN Ketterer, D Espinouse, M Chomarat, et al.
Blood|June 1, 1993
Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemiasR Rimokh, F Berger, G Delsol, et al.
Pageof 29

Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
Leukemia|October 8, 2004
FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)S Camilleri-Broët, N Mounier, A Delmer, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphomaN Ketterer, G Salles, D Espinouse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphomaC Haioun, E Lepage, C Gisselbrecht, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Presse Medicale (Paris, France : 1983)|January 30, 1993
[Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas]N C Gorin, B Coiffier, M Hayat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1996
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'AdulteA Guerci, P Lederlin, F Reyes, et al.
The American Journal of Medicine|May 7, 1999
Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factorsN Ketterer, D Espinouse, M Chomarat, et al.
Blood|June 1, 1993
Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemiasR Rimokh, F Berger, G Delsol, et al.
Pageof 29